Results 121 to 130 of about 1,396,067 (212)

Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease

open access: yesGlia, 2009
Cannabinoid agonists might serve as neuroprotective agents in neurodegenerative disorders. Here, we examined this hypothesis in a rat model of Huntington's disease (HD) generated by intrastriatal injection of the mitochondrial complex II inhibitor ...
O. Sagredo   +11 more
semanticscholar   +1 more source

Stable Adult Hippocampal Neurogenesis in Cannabinoid Receptor CB2 Deficient Mice

open access: yes, 2019
The G-protein coupled cannabinoid receptor 2 (CB2) has been implicated in the regulation of adult neurogenesis in the hippocampus. The contribution of CB2 towards basal levels of proliferation and the number of neural progenitors in the subgranular zone (
Leonore Mensching   +4 more
core   +1 more source

The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine

open access: yesBiomedicines
Background/Objectives: Cannabinoid use is rising among patients undergoing spinal fusion, yet its influence on bone healing is poorly defined. The endocannabinoid system (ECS)—through cannabinoid receptors 1 (CB1) and 2 (CB2)—modulates skeletal ...
Gabriel Urreola   +9 more
doaj   +1 more source

CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling

open access: yes, 2012
The endocannabinoid system is knownto regulate neural progenitor (NP) cell proliferation and neurogenesis. In particular, CB2 cannabinoid receptors have been shown to promote NP proliferation. As CB2 receptors are not expressed in differentiated neurons,
Ortega, Zaira   +9 more
core   +1 more source

The photoswitchable cannabinoid azo‐HU308 enables optical control of Ca2+ dynamics in INS‐1 β‐cells via off‐target effects on TRPC channels

open access: yesFEBS Open Bio
Intracellular Ca2+ regulates insulin secretion from pancreatic β‐cells and is influenced by cannabinoid signaling. However, the hydrophobicity and complex pharmacology of cannabinoid ligands prevent precision receptor targeting, limiting our ...
Alexander E. G. Viray, James A. Frank
doaj   +1 more source

Human Skeletal Muscle Oxidative Capacity Is Improved By Cannabinoid Receptor 2 Antagonist (cb2)

open access: yes, 2015
Human Skeletal Muscle Oxidative Capacity Is Improved By Cannabinoid Receptor 2 Antagonist ...
Daniel Conde (4113673)   +10 more
core  

Design and syntheis of selective cannabinoid CB2 receptor agonists

open access: yes, 2020
The Endocannabinoid system contains at least two G-Protein coupled receptors (GPCR), the type 1 (CB1) and type 2 (CB2) cannabinoid receptors. The CB1 receptor is a widely distributed GPCR and particularly abundant in the brain and responsible for the ...
Mishra, Vikas Sujeetkumar
core   +1 more source

Research progress on the cannabinoid type-2 receptor and Parkinson’s disease

open access: yesFrontiers in Aging Neuroscience
Parkinson’s disease (PD) is featured by movement impairments, including tremors, bradykinesia, muscle stiffness, and imbalance. PD is also associated with many non-motor symptoms, such as cognitive impairments, dementia, and mental disorders.
Xiaoqi Yu   +4 more
doaj   +1 more source

Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor

open access: yes, 2000
The DRY motif, at the junction of transmembrane helix 3 and intracellular loop 2 of G protein-coupled receptors, is highly conserved. Mutations were introduced into the CB2 cannabinoid receptor to study the role of this motif in CB2 signaling.
Zvi Vogel   +3 more
core   +1 more source

Editorial: Therapeutic potential of the cannabinoid CB2 receptor

open access: yesFrontiers in Pharmacology, 2022
Reem Smoum   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy